The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
This is in partnership with Mepro Pharmaceuticals which have successfully developed and commercialised the Albendazole Chewable formulation
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
The International Society of Aesthetic Plastic Surgery reported that non-surgical procedures outnumbered surgical ones globally in 2020
The sales of medicines and other items sold through Jan Aushadhi Kendras have increased from Rs. 7.29 crore in 2014 to Rs. 1,470 crore by July 2024
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
Q1 Consolidated operating profit Up 8.3%; revenue grows 7% to Rs 3,349 crore
Subscribe To Our Newsletter & Stay Updated
